Los Angeles

The trials here

What the 4 trials at this site are about, from their registry records.

Conditions

• CIDP (chronic inflammatory demyelinating polyneuropathy)1 trial
• Colorectal cancer1 trial
• Kidney cancer1 trial
• Lung cancer1 trial

Phase

• Phase 33 trials
• Phase 21 trial

Status

• Recruiting3 trials
• Not yet recruiting1 trial

Lead sponsor

• Summit Therapeutics3 trials
• Dianthus Therapeutics1 trial

Running trials

• Not yet recruiting

  A Clinical Study of Ivonescimab in Combination With Cadonilimab or Ipilimumab for Advanced Renal Cancer

  NCT07877194· Phase 2· Summit Therapeutics· Source

• Recruiting

  Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer

  NCT07228832· Phase 3· Summit Therapeutics· Source

  Contact: Ning Chang, MD

• Recruiting

  Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1

  NCT06767514· Phase 3· Summit Therapeutics· Source

• Recruiting

  A Study to Evaluate the Efficacy and Safety of DNTH103 in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CAPTIVATE)

  NCT06858579· Phase 3· Dianthus Therapeutics· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• CIDP (chronic inflammatory demyelinating polyneuropathy)1 recruiting
• Colorectal cancer1 recruiting
• Kidney cancer1 recruiting
• Lung cancer1 recruiting